German Drugs of Abuse Testing Market 2016 - Explores Future Trends; and Provides Test Volume and Sales Forecasts, by Market Segment and Individual Assay

DUBLIN, November 26, 2015 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/6ln9lq/2016_future) has announced the addition of the "2016 Future Horizons and Growth Strategies in the German Drugs of Abuse Testing Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

This new report provides a comprehensive analysis of the German drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.

The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxphene.

During the next five years, the abused drug testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.

This unique study is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends; and provides test volume and sales forecasts, by market segment and individual assay.

Companies Mentioned

• Abbott Laboratories
• AdnaGen/Alere
• Agilent Technologies
• Bayer Healthcare
• Beckman Coulter/Danaher
• Biomedical Diagnostics
• BioMerieux
• Bio-Rad
• DiaSorin
• Eiken
• Fujirebio
• Grifols
• Instrumentation Laboratory
• Kyowa Medex
• Matritech/Alere
• Ortho-Clinical Diagnostics
• Quest Diagnostics
• Roche
• Siemens
• Sysmex
• Thermo Fisher
• Tosoh
• Wako
• Wallac/PE

For more information visit http://www.researchandmarkets.com/research/6ln9lq/2016_future

Media Contact:
Laura Wood
+353-1-481-1716,
press@researchandmarkets.net